An "in vivo" assay for the detection of mutants negative to CRM (cross-reacting material) is described. L-Arabinose-negative mutants of Escherichia coli B/r were grown on Casamino Acids-L-arabinose plates to which a 3-ml agar layer, containing antiserum to the L-arabinose-binding protein (ABP), had been applied. After incubation and partial lysis of the clones "in situ," the plates were refrigerated for 36 hr, rinsed of colonial growth with water, and observed for the presence or absence of an immune precipitation. ABP-minus and L-arabinose regulator (araC)-minus mutants do not produce a precipitin reaction. L-Arabinose isomeraseless (EC 5.3.1.4; araA), kinaseless (EC 2.7.1.16; araB), and epimeraseless (EC 5.1.3.a; araD) mutants produce precipitin reactions. Mutants of E. coli B/r generated by treatment of the wild type with ethyl methane sulfonate or ultraviolet irradiation were isolated, tested for L-arabinose uptake, and screened for the presence or absence of ABP by the described assay. The applications of such an assay are discussed.
The isolation of specific microbial mutants is often hampered by the effort involved in screening large numbers of potential mutant clones for the absence of the gene product. This is particularly the case when the function of the protein is unknown or when loss of the protein does not produce any easily observable phenotypic change. This paper describes the development of a technique that has been utilized for the isolation of L-arabinose-binding protein (ABP) negative mutants. This protein has been implicated in the transport of L-arabinose in Escherichia coli B/r; however, it appears not to be an absolute requirement for this transport, as Larabinose can enter the cell by alternative mechanisms (6, 12) .
The procedure involves growth of potential mutant clones on plates containing the inducer (L-arabinose), an additional carbon source, and sera containing antibody specific for purified ABP. The antibody is layered in agar on the surface before colonies are picked to or replicated onto the plate. After growth, partial lysis, and refrigeration, those colonies producing the antigen (ABP+) can be readily identified by the precipitin reaction in the layered antibody agar, whereas 604 nonproducers (ABP-) do not provide such a response.
The shorthand designation of the assay as an "in vivo" test for negative CRM-mutants is used to denote an immunological assay which identifies mutants that do not produce a protein capable of interacting with antibody prepared against the functional gene product of the wild-type organism. Mutants 
MATERIALS AND METHODS
Chemicals and reagents. L-Arabinose-1-_4C was obtained from New England Nuclear Corp. Paper chromatography of the L-arabinose-1-_4C in water-saturated butanol followed by radioautography indicated that 100% of the 14C was associated with the L-arabinose spot. Ethyl methane sulfonate was obtained from Eastman Organic Chemicals. Casamino Acids and Larabinose were purchased from Difco and the Sigma Chemical Co., respectively. Bacterial strains. Previously described arabinosenonutilizing mutants of E. coli B/r used in this study are described in Table 1 . New mutants obtained in this study are described in the Results section.
Growth and treatment of cells for the isolation of mutants. Log-phase wild-type cells, grown in Luria broth, were centrifuged, washed, and suspended to a cell density of approximately 5 x 108 cells per ml in 0.7% K2HPO4, 0.3% KH2PO4, and 0.012% MgSO4 as described by Gross and Englesberg (5) . Samples (10 ml) were irradiated in petri dishes with a dose of ultraviolet irradiation giving a survival of 10-5. Samples of the irradiated suspension were diluted and plated on EMB arabinose plates. Arabinose-negative colonies were purified and further tested to ascertain the nature of the mutation. L-Arabinose-negative mutations were also generated by using ethyl methane sulfonate as described by Osborn (8) . The number of L-arabinose-negative mutants was enhanced by growing the mutagenized cells for 3 hr in minimal arabinose broth containing 500 units of penicillin per ml, before plating on EMB arabinose. L-Arabinose uptake-deficient mutants of FaraA39 were isolated by plating mutagenized cultures on the low-phosphate medium described by Englesberg (3) .
Metabolic assays. L-Arabinose isomerase was assayed by the Millipore-toluene method of Helling et al.
(manuscript in preparation). The assay involves collecting and washing samples at known cell densities on membrane filters (Millipore Corp., Bedford, Mass.) which are then placed directly in the L-arabinose isomerase reaction mix (4) containing toluene to make the cells permeable. Ribulose formed is assayed by the cysteine-carbazole procedure (1) . The L-arabinose permease activity was determined by measuring the uptake of L-arabinose-1-_4C using the Millipore technique previously described (4, 7) . A final concentration of L-arabinose of 2 x 10-8 M was used.
Preparation of antibody. ABP was purified from FaraA39 by the method of Hogg and Englesberg (6) . Acrylamide-gel electrophoresis of the purified material indicated that only one protein was present. New Zealand white rabbits were injected intramuscularly with 8 mg of purified protein suspended in complete Freund's adjuvant (4 mg per flank). On day 10, 2 mg of purified ABP was administered to each hind foot pad. Seven days after the last administration of ABP, a sample of blood was removed, and the sera were tested for the presence of antibody. Thereafter, 30-to 40-ml samples were removed by cardiac puncture, and the sera were recovered. Complement was inactivated by heating the serum at 56 C for 30 min. Booster shots of purified binding protein were administered at 3-week intervals. Sera obtained gave equivalence points when reacted with 50 to 200 gammas of antigen per ml of serum, depending on the pool of antisera used. The sera gave a single sharp line, when tested by the method of Ouchterlony (10), against either purified ABP or crude cellfree extracts from induced cultures. The serum was stored frozen in 5-ml volumes.
"In vivo" CRM detection. Plastic petri plates containing 25 ml of CH-arabinose-agar were used throughout this study. The medium contained: Casamino Acids, I %; K2HPO4, 0.7%; KH2PO4, 0.3%; (NH4)2S04, 0.1%; MgSO4, 0.01%; L-arabinose, 0.4%; agar, 1.5%. Agar (1.5%) in water was sterilized and stored in 20-ml volumes for use in layering. Serum plates were prepared daily by mixing 3 ml of molten agar (56 C) with 1 ml of serum and pouring the mixture in an even layer (as for phage plates) over the CH-arab- 
RESULTS
Development of the plate assay. The ease with which CRM-negative or ABP-positive mutants can be identified by the assay can best be seen in Fig. 1 . Known mutants of E. coli B/r were grown and lysed on the Casamino Acids-arabinose-antibody plate. The plate demonstrates that only strains previously shown to produce ABP (6) give a positive response, whereas those previously shown to be ABP-are negative in this test also. The weak response of the wild-type organism (spot 1) is attributed to catabolite repression of binding protein expression. It has been previously reported that ABP can be isolated from wild-type strains only when they have been cultured in a chemostat under conditions of arabinose starvation (6). F-araA39 and F-araA39 araEl (spots 2 and 3) both contain the ABP and give strong positive immunological responses. F-araA2, F-araA2 araEl, and F-araEl [isolated in the araA2 genetic background which is known to differ from the araA39 genetic background in that it appears to lack or have extremely low levels of the ABP (6)] (spots 4, 5, and 6) are all binding-protein negatives, as are F-araC3, F-araC19, and F-ara-CA719 (spots 7, 8, and 9), strains which are regulatory, pleiotrophic-negative mutants. Spots 10, I 1, and 12 demonstrate that araB mutants, constitutive mutants, and araD araAB deletion mutants provide positive responses. All mutants known to produce the binding protein, except those producing it at extremely low levels, provide positive immunological responses under the conditions of the assay. Binding protein and regulatory, pleiotrophic-negative mutants do not produce any crossreacting material. The large diffuse rings best seen around locations 2, 4, and 7 are attributed to interactions which result from previous exposure of the rabbits to microbial antigens. However, this reaction has never been strong enough to result in ambiguity on the plates, and could be reduced or eliminated by prior absorption of the serum with noninduced E. coli cell-free extracts. Figure 2 represents a sample of low-permease mutants spotted on a symmetrical 2,4,6,6,4,2 grid. Several potential ABP-minus mutants appear to be present.
During the development of this assay, a number of media were tried; these included Luria agar, nutrient agar, tryptone agar, and supplemented minimal agar. The Casamino Acids medium was found to give the most consistent results. Penicillin, lysozyme, and P lbt bacteriophage sprays were also tested as lysing agents. The chloroform-toluene-saturated filter discs or simply aging appeared best, as they do not have the disadvantages of puddling and blurred precipitin reactions often observed with the spray methods. The diameter of the precipitin reaction could be readily altered, depending on the amount and titer of the antiserum included in the agar layer. Lower amounts or titers result in larger diffuse reactions that tend to overlap on plates with a large number of colonies. The technique is readily adapted to replication if an even distribution of 25 to 75 colonies per plate exists. Marking the location where expected colonies did not grow will eliminate mistaking the absence of precipitin for a negative mutant when the rinsed plate is viewed.
Isolation of mutants from araA2 and araA39. In our consideration of the association between the ABP and arabinose uptake in E. coli, we are assuming that arabinose may be transported into the cell by more than one system (12) . Each system may contain several components, and the possibility of a common functional unit cannot be eliminated. It is also conceivable that a component stimulates but is not required by a given system. Mutants which one might expect to find should fall into two broad classes, (i) those which have reduced capacities for arabinose uptake while retaining maximal levels of ABP, and (ii) those which have reduced uptake capacities and reduced levels of the ABP. Extremely low levels of uptake will probably not be observed in that the contribution of nonspecific uptake often exceeds 5 to 10% of the normal induced level. For this reason we have concentrated on obtaining mutants with reduced but not necessarily absent MUTANTS NEGATIVE TO L-ARABINOSE FIG. 1. Test strains of Escherichia coli B/r were grown on the CH-arabinose antibody-containing plates, lysed, and refrigerated, and the colonies were removed by washing with water. Spots: 1, UPIOOI, wild type; 2, UP1041, F-araA39; 3, SB5313, F-araA39 araEl; 4, UP1009, F-araA2; 5, UP1664, F-araA2 araEl; 6, UP1654, F-araEl; 7, UPIOIO, F-araC3; 8, UP1022, F'araCI9; 9, SB1094, F'araCA719; 10, UP1013, FaraB6; 11, SB5159, F-araB24 araCc67; 12, SB1033, FaraD139 araA735thr-. uptake capacities. F-araA39 has been reported to contain large amount of the ABP, whereas FaraA2, a strain nonisogenic with the former, does not (6) . Mutants which are deficient in the uptake of L-arabinose were isolated from the araA2 genetic background by Englesberg using a selection on low-phosphate media (3) . These mutations effect a gene araE, which is unlinked to the other genes of the arabinose operon. When the lowphosphate selection method is applied to FaraA39, such arabinose uptake mutants are not obtained. It is possible that the inability to obtain uptake-deficient mutants in strain F-araA39 is the result of the large amounts of ABP present in this strain that are absent in F-araA2. Transduction of araE mutations from the araA2 genetic background into the araA39 genetic background results in a substantial decrease in the arabinose uptake capacity. F-araA39 and F-araA39 araEl have always provided higher levels of uptake than F-araA2 and F-araA2 araEl, respectively (unpublished data). 
DISCUSSION
The study of transport at a genetic or molecular level has been complicated by the apparent complexity of the process. The immunological assay described was developed to aid in such an analysis of L-arabinose transport in E. coli. Four ABP-minus mutants have been isolated. A genetic analysis of the mutants is in progress, and it is hoped that characteristics of the ABP locus and the araE locus will afford some insight into the transport process. In view of the central regulatory role of the araC gene, and the demonstration by complementation and isomerase assay of functional araC gene product in the mutants obtained, it is considered unlikely that ABP synthesis would be controlled by a secondary regulatory gene, and therefore the mutants obtained probably represent structural gene mutations. The major limitation of the assay is that it identifies only ABP-negative mutants which are nonsense, frameshift, or large deletions.
The technique is presently being used to map the approximate location of the ABP gene by mating streptomycin-sensitive, ABP+ 
